Nonmodifiable characteristics associated with nonadherence to immunosuppressant therapy in renal transplant recipients

American Journal of Health-System Pharmacy

Volumn 65, Issue 13, 2008, Pages 1242-1247

  Chisholm Burns, Marie A ^a   Kwong, W Jaqueline ^b   Mulloy, Laura L ^c   Spivey, Christina A ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UACP ^*

Author keywords

Age; Compliance; Immunosuppressive agents; Patients; Race; Sex; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; DRUG BLOOD LEVEL; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACY; PRIORITY JOURNAL; RACE DIFFERENCE; REGRESSION ANALYSIS; STATISTICAL MODEL;

EID: 46049107374     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070630     Document Type: Article

References (44)

1. Simpson SH, Eurich DT, Majumdar SR et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333:15-20.
2. Matas AJ, Humar A, Gillingham KJ et al. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int. 2002; 62:704-14.
3. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341:1725-30.
4. Butler JA, Peveler RC, Roderick P et al. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation. 2004; 77:786-9.
5. Chisholm MA, Mulloy LL, Jagadeesan M et al. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant. 2001; 15:330-6.
6. Frazier P, Davis-Ali S, Dahl K. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994; 8:550-7.
7. Greenstein S, Siegal B. Compliance and noncompliance in patients with functioning renal transplant: a multicenter study. Transplantation. 1998; 66:1718-26.
8. Chisholm MA, Bagby TR, DiPiro JT et al. Cost analysis of renal transplantation recipients' medications 1 -year post transplantation: identification of strategies for pharmacist interventions. Pharmacotherapy. 1998; 18:1174.
9. DeGeest S, Borgermans L, Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995; 59:340-7.
10. Didlake RH, Dreyfus K, Kerman RH et al. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc. 1988; 20:63-9.
11. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation. 1995; 60:914-20.
12. Gaston R, Hudson S, War M et al. Late renal allograft loss: noncompliance masquerading as chronic rejection. Transplant Proc. 1999; 31:21s-3s.
13. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts: overriding effects of HLA matching socioeconomic factors. N Engl J Med. 1992; 327:840-5.
14. Chisholm MA, Lance CE, Williamson GM et al. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005; 59:13-20.
15. Chisholm MA, Kwong WJ, Spivey CA. Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy. Transplantation. 2007; 84:1145-50.
16. Denhaerynck K, Steiger J, Bock A et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant. 2007; 7:108-16.
17. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation. 1993; 55:51-6.
18. Rosenberger J, Geckova AM, van Dijk JP et al. Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients. Transplant Int. 2005; 18:1072-8.
19. Schweizer RT, Rovelli M, Palmeri D et al. Noncompliance in organ transplant recipients. Transplantation. 1990; 49:374-7.
20. Siegal BR, Greenstein SM. Postrenal transplant compliance from the perspective of the African-Americans, Hispanic-Americans, Anglo-Americans. Adv Ren Replace Ther. 1997; 4:46-54.
21. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health-Syst Pharm. 2005; 62:1775-81.
22. Weng FL, Israni AK, Joffe MM et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005; 16:1839-48.
23. Rovelli M, Palmeri D, Vossler E et al. Noncompliance in renal transplant recipients: evaluation by socioeconomic groups. Transplant Proc. 1989; 21:3979-81.
24. Rovelli M, Palmeri D, Vossler E et al. Noncompliance in organ transplant recipients. Transplant Proc. 1989; 21:833-4.
25. Ghods AJ, Nasrollahzadeh D. Noncompliance with immunosuppressive medications after renal transplant. Exp Clin Transplant. 2003; 1:39-47.
26. Raiz LR, Kilty KM, Henry ML et al. Medication compliance following renal transplantation. Transplantation. 1999; 68:51-5.
27. Sketris I, Waite N, Grobler K et al. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc. 1994; 26:2538-41.
28. Insel K, Morrow D, Brewer B et al. Executive function, working memory, and medication adherence among older adults. J Gerontol. 2006; 61B:102-7.
29. Butler JA, Peveler RC, Roderick P et al. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant. 2004; 19:3144-9.
30. Meigs JB. Epidemiology of the insulin resistance syndrome. Curr Diab Rep. 2003; 3:73-9.
31. Ng N, Van Minh H, Tesfaye F et al. Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition. Scand J Public Health. 2006; 34:199-208.
32. Stewart RB, Caranasos MD. Medication compliance in the elderly. Med Clin North Am. 1989; 3:1551-63.
33. Bieszk N, Patel R, Heaberlin A et al. Detection of medication nonadherence through review of pharmacy claims data. Am J Health-Syst Pharm. 2003; 60:360-6.
34. World Health Organization. Adherence to long-term therapies. Evidence for action 2003. www.emro.who.int/ncd/Publications/adherence_report.pdf (accessed 2007 Jun 20).
35. Vik SA, Hogan DB, Patten SB et al. Medication nonadherence and subsequent risk of hospitalization and mortality among older adults. Drugs Aging. 2006; 23:345-56.
36. Roth MT, Ivey JL. Self-reported medication use in community-residing older adults: a pilot study. Am J Geriatr Pharmacother. 2005; 3:196-204.
37. Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 2001; 35:539-45.
38. Morrell RW, Park DC, Kidder DP et al. Adherence to antihypertensive medications across the life span. Gerontologist. 1997; 37:609-19.
39. Park DC, Willis SL, Morrow D et al. Cognitive function and medication usage in older adults. J Appl Gerontol. 1994; 13:39-57.
40. Salas M, In't Veld BA, van der Linden PD et al. Impaired cognitive function and compliance with antihypertensive drugs in elderly: the Rotterdam Study. Clin Pharmacol Ther. 2001; 70:561-6.
41. Johnson MJ, Williams M, Marshall ES. Adherent and nonadherent medication-taking in elderly hypertensive patients. Clin Nurs Res. 1999; 8:318-35.
42. Chisholm MA, Vollenweider LJ, Mulloy LL et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation. 2000; 70:1240-4.
43. Organ Procurement and Transplantation Network. National data. www.optn.org/latestData/step2.asp (accessed 2007 Jul 9).
44. Butler JA, Roderick P, Mullee M et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004; 77:769-76.